Physician

Yusuf Qamruzzaman, MD

According to 2025 Medicare claims, Yusuf Qamruzzaman, MD (NPI: 1174738231) practices hematology/oncology in the Warren-Troy-Farmington Hills, MI market, with the plurality of this provider's patient population coming from Oakland, MI. This provider's primary affiliated billing organization is MICHIGAN HEALTHCARE PROFESSIONALS PC (NPI: 1295023547; TIN: 451674932) and primary practice location at 48073-9998. Qamruzzaman is affiliated with the Honest ACO of Michigan LLC (ACO ID: D0236), participating under the REACH model.

Qamruzzaman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 622 traditional Medicare patients, billed 119,113 HCPCS/CPT codes, and received $1,427,418 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,080 prescription claims across 212 beneficiaries totaling $3,301,369 in drug costs, led by Imbruvica (Ibrutinib). 2019 DME data shows 32 claims. Open Payments data shows 40 records totaling $777. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $647,680 to $1,427,418. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $512,419 to $3,301,369. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$841K$1.7M2015 Medicare payment: $647,680 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $741,442 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $120,323 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $921,828 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,417,541 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,393,143 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,681,715 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,654,053 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,681,205 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,427,418 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201591025,790$647,680
201688736,698$741,442
20175662,478$120,323
201848847,173$921,828
2019603101,019$1,417,541
2020554120,336$1,393,143
2021579105,481$1,681,715
2022583122,346$1,654,053
2023589120,037$1,681,205
2024622119,113$1,427,418

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.7M$3.3M2015 Drug cost: $512,419 (USD; Tot_Drug_Cst)2016 Drug cost: $1,874,721 (USD; Tot_Drug_Cst)2017 Drug cost: $1,411,115 (USD; Tot_Drug_Cst)2018 Drug cost: $1,363,534 (USD; Tot_Drug_Cst)2019 Drug cost: $1,730,426 (USD; Tot_Drug_Cst)2020 Drug cost: $2,474,252 (USD; Tot_Drug_Cst)2021 Drug cost: $2,336,609 (USD; Tot_Drug_Cst)2022 Drug cost: $2,645,614 (USD; Tot_Drug_Cst)2023 Drug cost: $2,698,815 (USD; Tot_Drug_Cst)2024 Drug cost: $3,301,369 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015143542$512,419
2016180800$1,874,721
2017166705$1,411,115
2018169693$1,363,534
2019161836$1,730,426
20201511,029$2,474,252
20211711,014$2,336,609
20222061,090$2,645,614
20232181,114$2,698,815
20242121,080$3,301,369

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$2.5K$5.0K2015 Medicare payment: $4,999 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $2,582 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $3,047 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R39$4,999
2016N/R25$2,582
2017N/RN/RN/R
2018N/RN/RN/R
2019N/R32$3,047
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more234587$96
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's245613$13
36415Insertion of needle into vein for collection of blood sample4591,217$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count4421,183$8
84100Phosphate level209346$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
ImbruvicaIbrutinib381,088$620,901
LenalidomideLenalidomide23567$290,604
VyndamaxTafamidis13390$271,355
XtandiEnzalutamide16480$224,995
BrukinsaZanubrutinib13390$195,683

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.40$777Novartis Pharmaceuticals Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Yusuf Qamruzzaman, MD?

Tedicare shows public-source Medicare data for Yusuf Qamruzzaman, MD (NPI 1174738231), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Yusuf Qamruzzaman, MD have ACO affiliation data?

Yusuf Qamruzzaman, MD is shown with ACO affiliation data for Honest ACO of Michigan LLC (REACH, ACO ID D0236).

What billing organization is linked to Yusuf Qamruzzaman, MD?

Yusuf Qamruzzaman, MD is linked to MICHIGAN HEALTHCARE PROFESSIONALS PC (billing NPI 1295023547) in the available physician profile data.

Does Yusuf Qamruzzaman, MD have Open Payments data?

Yusuf Qamruzzaman, MD has 40 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.